Figure 2: Diagram showing the crosstalk between the M2 and M3 muscarinic acetylcholine receptors in atrial cells.

The pharmacotherapy of schizophrenia is currently dominated by atypical antipsychotics that primarily target dopaminergic signalling, the dysregulation of which has long been considered to have a ...